Clinical Research Directory
Browse clinical research sites, groups, and studies.
Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery
Sponsor: Mayo Clinic
Summary
The purpose of this research is to see if the use of tamsulosin can decrease both the incidence and duration of urinary retention, as well as hospital length of stay following spine surgery.
Official title: The Use of an Uroselective Alpha-1-antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery
Key Details
Gender
All
Age Range
35 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-04-10
Completion Date
2028-12-31
Last Updated
2026-04-03
Healthy Volunteers
No
Conditions
Interventions
Uroselective alpha-1-adrenergic receptor antagonist
Subjects will receive Tamsulosin (0.4 mg daily) beginning 5 days prior to surgery and for the duration of the postoperative hospital stay (approximately 8-12 days)
Placebo
Subjects will receive placebo beginning 5 days prior to surgery and for the duration of the postoperative hospital stay (approximately 8-12 days)
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States